You Position: Home > Paper
Clinical application recommendations on safety of gadolinium contrast agents
( views:749, downloads:2262 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Radiology
- Issue:
- 7
- DOI:
- 10.3760/cma.j.issn.1005-1201.2019.07.002
- Key Word:
- 钆对比剂;安全性;不良反应;肾源性系统性纤维化;脑沉积
Abstract： 目前普遍认为钆对比剂是安全的,但仍有极少数患者会出现严重不良反应.基于肾源性系统性纤维化及脑部钆沉积等新证据的出现,中华医学会放射学分会磁共振学组、质量控制与安全工作委员会的专家在参考国内外指南及相关文献的基础上,结合我国实际情况,制定了本版专家建议.本建议中叙述了钆对比剂的分类和理化特性,提出了临床安全性应用的基本原则,总结了肾源性系统性纤维化等钆对比剂相关不良反应,对肾功能不全、妊娠、哺乳、儿童等特殊人群的应用进行了推荐,并就钆对比剂的脑沉积问题提出了建议.
- [1]汤敏,伍建林.脑内钆对比剂沉积MRI研究现状与进展[J].2018,(12).
- [2]孔莹,李梦双,陈柱典,等.多次使用钆对比剂后MRI平扫小脑齿状核T1WI信号增高的初步研究[J].2018,(12).
- [3]中华医学会放射学分会,中国医师协会放射医师分会.对比剂使用指南（第1版）[J].2008,(3).
- [4]裴磊,许晶晶,张敏鸣.磁共振平扫T1加权像脑内核团高信号与钆对比剂注射次数的相关性[J].2017,(5).
- [5]Giusti L.,Berruto F.,Hoelbling C.,etc.Study of the 't Hooft model with the overlap Dirac operator - art. no. 094516[J].2002,65(9 Pt.B).
- [6]Ravi, Bhargava,Gabriele, Hahn,Wolfgang, Hirsch,etc.Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practice.[J].2013,6.
- [7]Kanda, Tomonori,Osawa, Marie,Oba, Hiroshi,etc.High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration[J].2015,275(3).
- [8]Behzadi, Ashkan Heshmatzadeh,Zhao, Yize,Farooq, Zerwa,etc.Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis[J].2018,286(2).
- [9]Jost, Gregor,Frenzel, Thomas,Lohrke, Jessica,etc.Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue[J].2017,27(7).
- [10]Thomas Grobner.Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?[J].2006,21(4).
- [11]Lancelot, Eric.Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion[J].2016,51(11).
- [12]S E, Cowper,H S, Robin,S M, Steinberg,etc.Scleromyxoedema-like cutaneous diseases in renal-dialysis patients.[J].2000,356(9234).
- [13]Jost, Gregor,Lenhard, Diana Constanze,Lohrke, Jessica,etc.Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents Comparison of Linear and Macrocyclic Agents[J].2016,51(2).
- [14]Radbruch, Alexander,Haase, Robert,Kieslich, Pascal J.,etc.No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents[J].2017,282(3).
- [15]Robert J, McDonald,Jennifer S, McDonald,David F, Kallmes,etc.Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities.[J].2017,(Spec ).
- [16]Hiroki Kawaguchi,Kazunari Ishii,Kazuhiro Kitajima,etc.High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.[J].2014,270(3).
- [17]Idee JM,Port M,Robic.Role of thermodynamic and kinetic parameters in gadolinium chelate stability.[J].2009,30(6).
- [18]Weberling, Lukas D.,Kieslich, Pascal J.,Kickingereder, Philipp,etc.Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration[J].2015,50(11).
- [19]Lengsfeld P,Hutter J,Weinmann HJ,etc.Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C.[J].2008,43(12).
- [20].Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury[J].2007,11(2).
- [21]R A, Kubik-Huch,N M, Gottstein-Aalame,T, Frenzel,etc.Gadopentetate dimeglumine excretion into human breast milk during lactation.[J].2000,216(2).